空输液袋市场按材料类型、容量、最终用户、分销管道和应用划分－2025-2032年全球预测

预计到 2032 年，空输液袋市场规模将达到 62.4 亿美元，复合年增长率为 5.69%。

主要市场统计数据
基准年 2024	40亿美元
预计年份：2025年	42.3亿美元
预测年份：2032年	62.4亿美元
复合年增长率 (%)	5.69%

本文全面概述了材料创新、监管变化和不断发展的医疗服务模式如何重新定义空输液袋的临床和供应链优先事项。

空输液袋环节涉及临床、供应链工程和材料科学等多个领域，因此对于以安全性、便携性和成本效益为优先的医疗服务模式至关重要。近年来，製造、采购和临床运营等各相关人员积极应对不断变化的监管要求，推动了可萃取物和可萃取物的研发，促使他们转向其他聚合物化学材料，并拓展了除传统医院药房之外的分销管道。随着以患者为中心的护理和居家医疗的快速发展，输液容器的设计和可用性直接影响治疗流程、库存计划和无菌物流。

医疗服务提供者和供应商也在适应新的采购模式。医院和诊所要求更高的无菌性、可预测的保质期以及与多种疗法的兼容性，而家庭护理服务提供者则优先考虑便携性、易用性和安全处置。这些日益增长的压力促使製造商在薄膜挤出、焊接技术和无菌填充工艺方面进行创新，并与材料专家和契约製造製造商合作，以提供差异化的产品特性。因此，空输液袋的市场格局不再仅仅由设备外形决定，而是由一个连接原料采购、製造精度、分销可靠性和临床性能的生态系统决定。

为什么材料替代、分散式护理、多元化分销和加强监管正在从根本上改变製造和采购的动态

随着医疗服务体系的技术成熟和结构性变革，空输液袋市场正经历几个变革性的转变。首先，从传统的PVC配方转向非PVC配方，既反映了监管机构的严格审查，也反映了临床医生对减少塑化剂迁移的需求。这项转变推动了EVA和聚乙烯配方的新一轮研发，力求在柔韧性、阻隔性能和加工性能之间取得平衡。同时，随着供应商寻求降低地缘政治事件和物流中断对其供应链的风险，生产规模和地理分布也在重新评估。

其次，分散式医疗模式（例如家庭输液和不断扩展的门诊服务）的兴起，催生了对更多规格和包装形式的药品的需求，以支持便携性和便捷给药。第三，分销通路正在多元化。虽然医院药局仍然是主要的采购点，但线上药局平台和现代零售药局正成为某些产品领域的重要接触点，这改变了库存管理预期和监管方式。最后，强调适用性、可萃取物检测和上市后竞争监测的法规，将品质保证置于竞争优势的最前沿，促使製造商采用完善的验证通讯协定和可追溯性系统，以增强临床医生的信心并获得支付方的认可。

2025年关税调整对空输液袋供应链的采购、近岸外包和製造弹性的综合影响

2025年关税和贸易措施带来的政策环境正在对空输液袋价值链的筹资策略、成本结构和供应商选择产生累积影响。对聚合物进口及相关医用级包装组件征收的关税增加了部分成品和原材料的总到岸成本，促使采购团队重新评估其供应商组合，并加快对更靠近终端市场的替代供应商进行资格认证。为此，许多製造商正在调整其供应商结构，倾向于选择国内或近岸合作伙伴，而另一些製造商则正在寻求材料改良策略，以减少对高关税原材料的依赖。

这些变化也影响资本配置决策。面对投入成本波动加剧，製造商优先投资于弹性挤出生产线和模组化无尘室设施，以便快速切换PVC和非PVC材料，避免关税造成的生产中断。分销合作伙伴和医院系统则透过增加关键SKU的库存缓衝措施来应对，同时收紧供应商的绩效考核指标。此外，关税环境凸显了全面成本效益分析的重要性，该分析应涵盖关税、运费和合规成本，迫使买卖双方寻求风险共担、激励奖励而非仅仅追求销售的合约安排。

策略性细分考量将材料化学、销售因素、终端用户需求、分销管道和临床应用限制等因素与竞争定位联繫起来。

有效的细分主导策略能够识别材料成分、容器容量、终端用户需求、分销管道和临床应用等方面的差异，并据此调整产品开发和开发方法。目前，材料分为聚氯乙烯（PVC）基材料和非PVC基材料，製造商将研发重点放在非PVC材料中的乙烯醋酸乙烯共聚物（EVA）和聚乙烯上，以期在柔韧性、化学相容性和生产效率之间取得理想的平衡。材料的选择必须与临床应用的需求相符，因为它直接影响灭菌方式、储存稳定性以及与亲油性或敏感药物製剂的相容性。

容量范围从​​紧凑型 100 毫升到大型 1000 毫升，还包括 250 毫升和 500 毫升的中型容量，这导致在操作人体工学、添加剂需求和运输经济性等方面需要权衡设计。诊所和居家医疗机构优先考虑易用性、简化的给药方式和安全处置，而医院则要求容量、与输液系统的互通性以及严格的品质文件。即使在医院内部，公立医院和私立医院也可能有不同的采购法规和品质验收标准，因此需要不同的合约方式。分销管道影响药品的供应和客户体验：医院药房专注于批量采购和连锁物流；线上药房创建直接面向消费者的管道，需要清晰的标籤检视和退货处理；而零售药房则注重提高照护现场的取药便利性，重点关注货架陈列和员工培训。用于脱水治疗的产品需要强大的屏障性能和清晰的剂量说明；药物递送系统需要与多种活性药物成分相容；而营养支持，无论是中心给药还是外周给药，都需要能够保持营养成分稳定性并支持无菌製剂通讯协定的解决方案。透过沿着每个细分维度调整产品系列，製造商和负责人可以优化临床适用性、法规合规性和商业性成功。

分析美洲、欧洲、中东和非洲以及亚太地区的区域动态和采购偏好，为采购、监管策略和分销模式提供资讯。

每个地区的动态差异显着，为相关人员在製定与各地区医疗服务模式和管理体制相适应的供应策略时带来了不同的机会和风险。在美洲，采购往往优先考虑供应商的可追溯性、严格遵守药典标准以及适应大型综合医疗体系。在欧洲、中东和非洲，监管环境各不相同，各国卫生部门和竞标流程都会影响产品的推广週期；与区域经销商和契约製造製造商建立策略伙伴关係可以加速市场渗透。在中东和非洲，基础设施的限制以及不断增长的私营部门投资正在推动对可靠、易用的产品的需求，以支持居家医疗和门诊护理。

亚太地区都市区三级医疗中心正迅速推进医疗器材的临床应用，并专注于发展在地化生产以支援国家医疗设备策略。区域供应链也正在适应出口主导动态和强调价值导向型采购的采购改革。在整个亚太地区，物流因素、关税风险和当地监管要求都在影响采购决策，成功的供应商正将本地监管专业知识与灵活的生产布局相结合，以满足客户多样化的需求。

卓越的製造流程、材料创新、监管领导力和灵活的分销能力如何定义市场领导地位和供应商差异化

在空输液袋领域，竞争地位越来越取决于製造流程、材料科学能力、监管领导力和分销灵活性的综合考量。领先的供应商正加大研发投入，以优化聚合物的萃取和浸出性能，同时拓展灭菌和无菌填充能力，从而满足医疗机构的采购标准。同时，受託製造製造商也正在扩大无尘室，并实施先进的製程控制，以减少批次差异，加快供应商与医院系统和集团采购组织的认证进程。

材料专家、医疗器材製造商和医疗保健机构之间的策略合作正在打造差异化的产品线，这些产品线强调临床医生使用便利性、药物相容性以及永续性考量，例如减少废弃物和提高可回收性。提供整合低温运输物流、库存管理解决方案和数位化订购介面的分销合作伙伴在分散的医疗保健环境中获得了更广泛的应用。最终，那些将技术性能与透明的品质系统、响应迅速的客户服务和灵活的生产布局相结合的公司，最有利于建立长期的机构合作关係，并能灵活应对政策变化和采购改革。

为製造商和供应商提供切实可行的营运和策略倡议，以增强韧性、加速临床应用并适应不断变化的采购优先事项。

产业领导者战术性行动，以增强韧性，加速临床差异化产品的推广应用，并使商业模式与不断变化的支付方和医疗服务提供者的期望保持一致。首先，应优先考虑材料多样化和製程灵活性，对PVC和非PVC平台进行认证，并对生产线维修以实现快速切换。其次，应透过投资于可萃取物和可浸出物测试、完善的稳定性方案以及透明的可追溯性，加强监管和品质保证能力，减少采购障碍，并加快医院认证进程。

第三，我们正在重组分销策略，以支持分散式医疗保健。我们正在开发适用于家庭输液和门诊环境的包装和给药方式，并与数位药房平台合作，在允许的情况下实现直接送药上门。第四，我们正在寻求近岸製造伙伴关係和策略性库存布局，以降低运费和关税负担，同时保持成本竞争力。最后，我们正在透过展示总体拥有成本 (TCO) 优势、提高病患安全性和工作流程效率，使我们的商业模式与以金额为准的采购保持一致。

严谨的混合方法研究途径，结合了主要相关人员访谈、技术文献综述、监管调查和情境三角验证，确保了分析的有效性。

本报告的调查方法结合了对主要相关人员的访谈、可靠的二手资讯综合以及系统性的三角验证，以确保分析的严谨性和实际应用价值。主要研究包括对製造业企业高管、医院和诊所采购负责人、参与输液治疗的临床负责人、委託製造。二手研究包括对监管指南、聚合物性能和萃取物测试的技术文献、贸易政策文件以及披露资本投资和产能扩张的公开文件的全面审查。

我们采用三角测量法对数据进行综合分析，该方法将定性研究结果与供应商公告和监管揭露进行交叉检验，并透过情境分析评估关税的营运影响。在适当情况下，我们还使用用例来说明成功的产品导入和近岸外包倡议，并与行业专家查核点检验，以验证有关生产前置作业时间、灭菌方法和分销模式的假设。这种综合方法确保结论既反映了实际营运情况，也反映了更广泛的政策技术背景。

对材料、製造、监管和分销变化的前瞻性综合分析，揭示了空输液袋相关人员的应对能力以及其临床应用路径。

总之，空输液袋产业正经历着由材料创新、医疗服务模式演变、分销管道多元化以及政策主导的供应链调整所驱动的重大变革时期。积极适应的相关人员——例如透过材料多元化、投资弹性製造、加强监管和品质体係以及调整分销策略以适应分散式医疗服务——将更有利于获得临床应用并有效控製成本波动。贸易政策变化带来的累积影响凸显了供应链韧性以及透过风险分担和奖励可靠性的合作性商业安排的重要性。

展望未来，製造商、医疗服务提供者和经销商必须在整个价值链上通力合作，确保产品设计、监管证据和物流能力得到整合，从而满足临床安全和营运效率的双重需求。这样做将有助于建立更可靠的输液治疗管道，支持居家医疗和门诊护理的扩展，并建立透明且行之有效的长期供应商-买家关係。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 用于空输液袋製造的可生物降解聚合物配方，以满足永续性目标
• 整合RFID追踪与区块链系统，实现空输液袋供应链的即时透明化
• 在全球产能受限的情况下，将空输液袋生产外包给专业合约生产商的做法正在兴起。
• 为满足复杂的药物配製通讯协定，模组化多腔空输液袋的需求日益增长。
• 严格遵守不含邻苯二甲酸酯且低析出物的空输液袋材料的监管规定
• 医院药局开始采用现场3D列印技术，为特殊治疗方法订製空输液袋
• 塑胶树脂供应商与输液袋製造商建立策略伙伴关係关係，确保原料供应。

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 依材料类型分類的空输液袋市场

• 不含聚氯乙烯
  • EVA
  • 聚乙烯
• PVC

9. 空输液袋市场（以销售量计）

• 100mL
• 1,000mL
• 250mL
• 500mL

第十章 按终端用户分類的空输液袋市场

• 诊所
• 居家医疗
• 医院
  • 公立医院
  • 私立医院

第十一章 按通路分類的空输液袋市场

• 医院药房
• 网路药房
• 零售药房

第十二章 按应用分類的空输液袋市场

• 脱水疗法
• 药物递送
• 营养支持
  • 中枢营养
  • 週边营养

第十三章 空输液袋市场（依地区划分）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十四章 依组别分類的空输液袋市场

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十五章 各国空输液袋市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十六章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • Baxter International, Inc.
  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Terumo Corporation
  • ICU Medical, Inc.
  • Nipro Corporation
  • Grifols, SA
  • Vygon SA
  • Poly Medicure Limited
  • Pfizer Inc.

The Empty IV Bags Market is projected to grow by USD 6.24 billion at a CAGR of 5.69% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 4.00 billion
Estimated Year [2025]	USD 4.23 billion
Forecast Year [2032]	USD 6.24 billion
CAGR (%)	5.69%

An integrative overview of how materials innovation, regulatory shifts, and evolving care delivery models are redefining clinical and supply chain priorities for empty IV bags

The empty intravenous (IV) bag sector sits at the intersection of clinical practice, supply chain engineering, and material science, and it has become increasingly central to healthcare delivery models that prioritize safety, portability, and cost-efficiency. Over recent years, stakeholders across manufacturing, procurement, and clinical operations have navigated evolving regulatory expectations for leachables and extractables, driven a transition toward alternative polymer chemistries, and responded to distribution channel diversification that extends beyond traditional hospital pharmacies. As patient-centric care and homecare expansion accelerate, the design and availability of IV containers now directly influence therapeutic workflows, inventory planning, and sterile logistics.

Healthcare providers and suppliers are also adjusting to new procurement paradigms. Hospitals and clinics seek higher assurance of sterility, predictable shelf life, and compatibility with a broader range of therapeutic agents, while homecare providers emphasize portability, ease of use, and safe disposal. These converging pressures are prompting manufacturers to innovate in film extrusion, welding technologies, and sterile filling processes, and they are stimulating partnerships with materials specialists and contract manufacturers to deliver differentiated product attributes. Consequently, the market context for empty IV bags is defined not just by device form factors, but by an ecosystem that connects raw material sourcing, manufacturing fidelity, distribution reliability, and clinical performance.

How material substitution, decentralized care, distribution diversification, and elevated regulatory focus are fundamentally transforming manufacturing and procurement dynamics

Several transformative shifts are reshaping the empty IV bag landscape, bridging technological maturation with structural changes in healthcare delivery. First, material substitution away from legacy PVC formulations toward non-PVC alternatives reflects both regulatory scrutiny and clinician demand for reduced plasticizer migration; this pivot is prompting new development cycles in EVA and polyethylene formulations that balance flexibility, barrier properties, and processability. At the same time, manufacturing scale and geographic diversification are being reconsidered as suppliers seek to de-risk supply chains exposed by geopolitical events and logistics disruptions.

Second, the rise of decentralized care models, including expanded home infusion and ambulatory services, is creating demand for a broader array of bag volumes and packaging configurations that support portability and simplified administration. Third, distribution channels are diversifying: while hospital pharmacies remain core procurement points, online pharmacy platforms and modern retail pharmacies are becoming meaningful conduits for certain product segments, which changes inventory management expectations and regulatory oversight. Finally, regulatory emphasis on compatibility, extractables testing, and post-market surveillance is elevating quality assurance as a competitive differentiator, encouraging manufacturers to adopt robust validation protocols and traceability systems that support clinician confidence and payer acceptance.

The compound consequences of 2025 tariff adjustments on procurement, nearshoring, and manufacturing flexibility across the empty IV bag supply chain

The policy environment created by tariffs and trade actions in 2025 has had a cumulative effect on sourcing strategies, cost structures, and supplier selection across the empty IV bag value chain. Tariffs on polymer imports and related medical-grade packaging components have increased the total landed cost of some finished goods and raw inputs, prompting procurement teams to reassess supplier portfolios and to accelerate qualification of alternative vendors closer to end markets. In response, many manufacturers have reweighted their supplier mixes to favor domestic or nearshore partners, while others have pursued material reformulation strategies that reduce reliance on tariffed feedstocks.

These shifts also affect capital allocation decisions. Faced with higher input volatility, manufacturers are prioritizing investments in flexible extrusion lines and modular cleanroom facilities that enable quicker changeovers between PVC and non-PVC materials, thereby insulating production from tariff-driven disruptions. Distribution partners and hospital systems have responded by increasing inventory buffer policies for critical SKUs while implementing tighter vendor performance metrics. Moreover, the tariff environment has accentuated the importance of comprehensive cost-to-serve analyses that incorporate duties, freight, and regulatory compliance costs, compelling both buyers and suppliers to pursue contractual arrangements that share risk and incentivize resilience rather than volume alone.

Strategic segmentation insights linking material chemistries, volume form factors, end-user requirements, distribution channels, and clinical application constraints to competitive positioning

An effective segmentation-driven strategy recognizes differences in material composition, container volume, end-user requirements, distribution pathways, and clinical applications, and tailors product development and Go-to-Market approaches accordingly. Materials now bifurcate into PVC and non-PVC families, and within the non-PVC category manufacturers are focusing development efforts on ethylene-vinyl acetate (EVA) and polyethylene to achieve the desired balance of flexibility, chemical compatibility, and manufacturing throughput. This material choice directly influences sterilization options, shelf stability, and compatibility with lipophilic or sensitive drug formulations, and therefore must be matched to clinical application needs.

Volume segmentation-ranging from compact 100 mL formats to large 1000 mL reservoirs, including intermediate 250 mL and 500 mL sizes-drives design trade-offs in handling ergonomics, additive requirements, and transport economies. End users present distinct priorities: clinics and homecare environments emphasize ease of use, simplified administration, and safe disposal, while hospitals demand scale, interoperability with infusion systems, and rigorous quality documentation; within hospitals, government institutions and private hospitals may follow different procurement rules and quality acceptance criteria, necessitating distinct contractual approaches. Distribution channels shape availability and customer experience, with hospital pharmacies focused on bulk procurement and chain logistics, online pharmacies creating direct-to-consumer pathways that require clear labeling and returns handling, and retail pharmacies offering point-of-care access that emphasizes shelf presentation and staff training. Clinical applications impose their own constraints: products intended for dehydration therapy demand robust barrier performance and dosing clarity, drug delivery requires compatibility with a wide spectrum of active pharmaceutical ingredients, and nutritional support-whether delivered centrally or peripherally-requires solutions that preserve nutrient stability and support aseptic compounding protocols. By aligning product portfolios with each segmentation axis, manufacturers and purchasers can optimize clinical fit, regulatory compliance, and commercial success.

Regional dynamics and procurement preferences across the Americas, Europe Middle East & Africa, and Asia-Pacific that inform sourcing, regulatory strategy, and distribution models

Regional dynamics vary markedly and offer differentiated opportunities and risks for stakeholders that align supply strategies with local healthcare delivery models and regulatory regimes. In the Americas, procurement tends to prioritize robust supplier traceability, compliance with stringent pharmacopoeial standards, and responsiveness to large integrated health systems; thus, manufacturers that demonstrate validated quality systems and domestic or nearshore production capabilities often find stronger adoption. Europe, the Middle East & Africa present a heterogeneous regulatory landscape where national health authorities and tender processes influence adoption cycles, and where strategic partnerships with regional distributors and contract manufacturers can accelerate market penetration. In the Middle East and Africa, infrastructure constraints and growing private sector investment drive demand for reliable, easy-to-use formats that support emergent homecare and ambulatory services.

Asia-Pacific exhibits rapid clinical adoption across urban tertiary centers and a growing emphasis on local manufacturing to meet national medical device strategies; regional supply networks are also adapting to export-led dynamics and to procurement reforms that emphasize value-based purchasing. Across all regions, logistics considerations, tariff exposures, and local regulatory requirements shape sourcing decisions, and successful suppliers combine regional regulatory expertise with flexible production footprints to meet differentiated customer expectations.

How manufacturing excellence, materials innovation, regulatory leadership, and distribution agility are coalescing to define market leadership and supplier differentiation

Competitive positioning in the empty IV bag sector is increasingly determined by a blend of manufacturing excellence, material science capability, regulatory leadership, and distribution agility. Leading suppliers are investing in R&D to optimize polymer formulations for extractable and leachables performance while scaling sterilization and aseptic filling competencies that meet institutional procurement thresholds. In parallel, contract manufacturing organizations are expanding cleanroom capacity and implementing advanced process controls that reduce batch variability and accelerate supplier qualification for hospital systems and group purchasing organizations.

Strategic collaborations between materials specialists, device makers, and healthcare providers are producing differentiated product lines that emphasize clinician usability, pharmacologic compatibility, and sustainability considerations such as reduced waste or improved recyclability. Distribution partners that offer integrated cold chain logistics, inventory management solutions, and digital ordering interfaces are achieving stronger adoption in decentralized care settings. Ultimately, companies that align technical performance with transparent quality systems, responsive customer service, and flexible manufacturing footprints are best positioned to capture long-term institutional relationships and to respond nimbly to policy shifts and procurement reforms.

Actionable operational and strategic initiatives for manufacturers and suppliers to build resilience, accelerate clinical adoption, and align with evolving procurement priorities

Industry leaders should pursue a set of tactical and strategic actions to strengthen resilience, accelerate adoption of clinically differentiated products, and align commercial models with evolving payer and provider expectations. First, prioritize material diversification and process flexibility by qualifying both PVC and non-PVC platforms and by retrofitting production lines for rapid changeovers; this reduces exposure to tariff shocks and raw material supply disruptions. Second, deepen regulatory and quality assurance capabilities by investing in extractables and leachables testing, robust stability protocols, and transparent traceability that reduce procurement barriers and accelerate hospital qualification timelines.

Third, reconfigure distribution strategies to support decentralized care: develop packaging and dosing formats for home infusion and ambulatory settings, and partner with digital pharmacy platforms to enable direct-to-patient fulfillment where permitted. Fourth, pursue nearshore manufacturing partnerships or strategic inventory positioning to mitigate freight and tariff exposures while maintaining cost-competitiveness. Finally, align commercial models with value-based procurement by demonstrating total cost of ownership benefits, improved patient safety profiles, or workflow efficiencies; this may involve bundled service offerings, performance-based contracts, or clinician training programs that reduce adoption friction.

A rigorous mixed-methods research approach combining primary stakeholder interviews, technical literature synthesis, regulatory review, and scenario-based triangulation to ensure analytical validity

The research methodology underpinning this report combines primary stakeholder engagement, robust secondary source synthesis, and systematic triangulation to ensure analytical rigor and practical relevance. Primary research included structured interviews with manufacturing executives, procurement leads from hospitals and clinics, clinical leadership involved in infusion therapy, contract manufacturers, and distribution partners; these conversations provided qualitative insights into production constraints, procurement priorities, and clinical usability considerations. Secondary research comprised a comprehensive review of regulatory guidance, technical literature on polymer performance and extractables testing, trade policy documents, and public filings that illuminate capital investments and capacity expansions.

Data were synthesized using a triangulation approach that cross-validated qualitative findings with supplier announcements and regulatory disclosures, and that assessed the operational implications of tariff actions through scenario analysis. Where appropriate, the methodology used case studies to illustrate successful product introductions and nearshoring initiatives, and validation checkpoints were embedded with industry experts to confirm assumptions about manufacturing lead times, sterilization modalities, and distribution models. This combined approach ensured that conclusions reflect both lived operational realities and the broader policy and technological context.

A forward-looking synthesis of material, manufacturing, regulatory, and distribution changes that converge to define resilience and clinical adoption pathways for empty IV bag stakeholders

In conclusion, the empty IV bag sector is experiencing a period of substantive transformation driven by material innovation, evolving care delivery models, distribution channel diversification, and policy-driven supply chain adjustments. Stakeholders that proactively adapt-by diversifying materials, investing in flexible manufacturing, strengthening regulatory and quality systems, and aligning distribution strategies with decentralized care-will be better positioned to capture clinical adoption and to manage cost volatility. The cumulative impacts of trade policy shifts have underscored the need for supply chain resilience and for collaborative commercial arrangements that distribute risk and incentivize reliability.

Moving forward, manufacturers, healthcare providers, and distributors must coordinate across the value chain to ensure that product design, regulatory evidence, and logistical capability converge to meet the twin imperatives of clinical safety and operational efficiency. By doing so, they will enable more reliable infusion therapy pathways, support the expansion of home and ambulatory care, and create enduring supplier-buyer relationships grounded in transparency and performance.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Adoption of biodegradable polymer formulations in empty IV bag production to meet sustainability targets
• 5.2. Integration of RFID tracking and blockchain systems for real-time empty IV bag supply chain transparency
• 5.3. Increased outsourcing of empty IV bag manufacture to specialized CMOs amid global capacity constraints
• 5.4. Rising demand for modular multi-chamber empty IV bags catering to complex drug reconstitution protocols
• 5.5. Stringent regulatory compliance for phthalate-free and low-extractables empty IV bag materials
• 5.6. Shift towards on-site 3D printing of customized empty IV bags in hospital pharmacies for niche therapies
• 5.7. Strategic partnerships between plastic resin suppliers and IV bag manufacturers to secure raw material supply

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Empty IV Bags Market, by Material Type

• 8.1. Non-PVC
  • 8.1.1. EVA
  • 8.1.2. Polyethylene
• 8.2. PVC

9. Empty IV Bags Market, by Volume

• 9.1. 100 mL
• 9.2. 1000 mL
• 9.3. 250 mL
• 9.4. 500 mL

10. Empty IV Bags Market, by End User

• 10.1. Clinics
• 10.2. Homecare
• 10.3. Hospitals
  • 10.3.1. Government Hospitals
  • 10.3.2. Private Hospitals

11. Empty IV Bags Market, by Distribution Channel

• 11.1. Hospital Pharmacies
• 11.2. Online Pharmacy
• 11.3. Retail Pharmacies

12. Empty IV Bags Market, by Application

• 12.1. Dehydration Therapy
• 12.2. Drug Delivery
• 12.3. Nutritional Support
  • 12.3.1. Central Nutrition
  • 12.3.2. Peripheral Nutrition

13. Empty IV Bags Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Empty IV Bags Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Empty IV Bags Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Analysis
  • 16.3.1. Baxter International, Inc.
  • 16.3.2. B. Braun Melsungen AG
  • 16.3.3. Fresenius Kabi AG
  • 16.3.4. Terumo Corporation
  • 16.3.5. ICU Medical, Inc.
  • 16.3.6. Nipro Corporation
  • 16.3.7. Grifols, S.A.
  • 16.3.8. Vygon S.A.
  • 16.3.9. Poly Medicure Limited
  • 16.3.10. Pfizer Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL EMPTY IV BAGS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL EMPTY IV BAGS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL EMPTY IV BAGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL EMPTY IV BAGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. AMERICAS EMPTY IV BAGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. EUROPE EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. AFRICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. ASEAN EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. GCC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. BRICS EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. G7 EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. NATO EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. GLOBAL EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. EMPTY IV BAGS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 30. EMPTY IV BAGS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. EMPTY IV BAGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL EMPTY IV BAGS MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL EMPTY IV BAGS MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NON-PVC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NON-PVC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NON-PVC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NON-PVC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NON-PVC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NON-PVC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL EMPTY IV BAGS MARKET SIZE, BY EVA, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL EMPTY IV BAGS MARKET SIZE, BY EVA, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL EMPTY IV BAGS MARKET SIZE, BY EVA, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL EMPTY IV BAGS MARKET SIZE, BY EVA, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL EMPTY IV BAGS MARKET SIZE, BY EVA, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL EMPTY IV BAGS MARKET SIZE, BY EVA, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL EMPTY IV BAGS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PVC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PVC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PVC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PVC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PVC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PVC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 100 ML, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 100 ML, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 100 ML, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 100 ML, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 100 ML, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 100 ML, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 1000 ML, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 1000 ML, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 1000 ML, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 1000 ML, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 1000 ML, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 1000 ML, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 250 ML, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 250 ML, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 250 ML, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 250 ML, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 250 ML, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 250 ML, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 500 ML, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 500 ML, BY REGION, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 500 ML, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 500 ML, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 500 ML, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL EMPTY IV BAGS MARKET SIZE, BY 500 ML, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOMECARE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOMECARE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOMECARE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOMECARE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOMECARE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL EMPTY IV BAGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL EMPTY IV BAGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL EMPTY IV BAGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL EMPTY IV BAGS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL EMPTY IV BAGS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL EMPTY IV BAGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL EMPTY IV BAGS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL EMPTY IV BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL EMPTY IV BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL EMPTY IV BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL EMPTY IV BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL EMPTY IV BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL EMPTY IV BAGS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DEHYDRATION THERAPY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DEHYDRATION THERAPY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DEHYDRATION THERAPY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DEHYDRATION THERAPY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DEHYDRATION THERAPY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DEHYDRATION THERAPY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL EMPTY IV BAGS MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CENTRAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CENTRAL NUTRITION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CENTRAL NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CENTRAL NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CENTRAL NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL EMPTY IV BAGS MARKET SIZE, BY CENTRAL NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PERIPHERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PERIPHERAL NUTRITION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PERIPHERAL NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PERIPHERAL NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PERIPHERAL NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL EMPTY IV BAGS MARKET SIZE, BY PERIPHERAL NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL EMPTY IV BAGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL EMPTY IV BAGS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 149. AMERICAS EMPTY IV BAGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 150. AMERICAS EMPTY IV BAGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 151. AMERICAS EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 152. AMERICAS EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
• TABLE 153. AMERICAS EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
• TABLE 154. AMERICAS EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
• TABLE 155. AMERICAS EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
• TABLE 156. AMERICAS EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
• TABLE 157. AMERICAS EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 158. AMERICAS EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 159. AMERICAS EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 160. AMERICAS EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 161. AMERICAS EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 162. AMERICAS EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 163. AMERICAS EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 164. AMERICAS EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 165. AMERICAS EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
• TABLE 166. AMERICAS EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
• TABLE 167. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 168. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 169. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 170. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
• TABLE 171. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
• TABLE 172. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
• TABLE 173. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
• TABLE 174. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
• TABLE 175. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 176. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 177. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 178. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 179. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 180. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 181. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 182. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 183. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
• TABLE 184. NORTH AMERICA EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
• TABLE 185. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 186. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 187. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 188. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
• TABLE 189. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
• TABLE 190. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
• TABLE 191. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
• TABLE 192. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
• TABLE 193. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 194. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 195. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 196. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 197. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 198. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 199. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 200. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 201. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
• TABLE 202. LATIN AMERICA EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
• TABLE 203. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 204. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
• TABLE 211. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 212. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 213. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 214. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 215. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 216. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 217. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 218. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 219. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
• TABLE 220. EUROPE, MIDDLE EAST & AFRICA EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
• TABLE 221. EUROPE EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 222. EUROPE EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 223. EUROPE EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 224. EUROPE EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
• TABLE 225. EUROPE EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
• TABLE 226. EUROPE EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
• TABLE 227. EUROPE EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
• TABLE 228. EUROPE EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
• TABLE 229. EUROPE EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 230. EUROPE EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 231. EUROPE EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 232. EUROPE EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 233. EUROPE EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 234. EUROPE EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 235. EUROPE EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 236. EUROPE EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 237. EUROPE EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
• TABLE 238. EUROPE EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
• TABLE 239. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 240. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 241. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 242. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
• TABLE 243. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
• TABLE 244. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
• TABLE 245. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
• TABLE 246. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
• TABLE 247. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 248. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 249. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 250. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 251. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 252. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 253. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 254. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 255. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
• TABLE 256. MIDDLE EAST EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
• TABLE 257. AFRICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 258. AFRICA EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 259. AFRICA EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 260. AFRICA EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
• TABLE 261. AFRICA EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
• TABLE 262. AFRICA EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
• TABLE 263. AFRICA EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
• TABLE 264. AFRICA EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
• TABLE 265. AFRICA EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 266. AFRICA EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 267. AFRICA EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 268. AFRICA EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 269. AFRICA EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 270. AFRICA EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 271. AFRICA EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 272. AFRICA EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 273. AFRICA EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
• TABLE 274. AFRICA EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
• TABLE 275. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 276. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 277. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 278. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
• TABLE 279. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
• TABLE 280. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
• TABLE 281. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
• TABLE 282. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
• TABLE 283. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 284. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 285. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 286. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 287. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 288. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 289. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 290. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 291. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
• TABLE 292. ASIA-PACIFIC EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
• TABLE 293. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 294. GLOBAL EMPTY IV BAGS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 295. ASEAN EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 296. ASEAN EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 297. ASEAN EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 298. ASEAN EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
• TABLE 299. ASEAN EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
• TABLE 300. ASEAN EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
• TABLE 301. ASEAN EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
• TABLE 302. ASEAN EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
• TABLE 303. ASEAN EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 304. ASEAN EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 305. ASEAN EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 306. ASEAN EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 307. ASEAN EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 308. ASEAN EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 309. ASEAN EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 310. ASEAN EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 311. ASEAN EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
• TABLE 312. ASEAN EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
• TABLE 313. GCC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 314. GCC EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 315. GCC EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 316. GCC EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
• TABLE 317. GCC EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
• TABLE 318. GCC EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
• TABLE 319. GCC EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
• TABLE 320. GCC EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
• TABLE 321. GCC EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 322. GCC EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 323. GCC EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 324. GCC EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 325. GCC EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 326. GCC EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 327. GCC EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 328. GCC EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 329. GCC EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
• TABLE 330. GCC EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
• TABLE 331. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 332. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 333. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 334. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
• TABLE 335. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
• TABLE 336. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
• TABLE 337. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
• TABLE 338. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
• TABLE 339. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 340. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 341. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 342. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
• TABLE 343. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 344. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
• TABLE 345. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 346. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 347. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2018-2024 (USD MILLION)
• TABLE 348. EUROPEAN UNION EMPTY IV BAGS MARKET SIZE, BY NUTRITIONAL SUPPORT, 2025-2032 (USD MILLION)
• TABLE 349. BRICS EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 350. BRICS EMPTY IV BAGS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 351. BRICS EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
• TABLE 352. BRICS EMPTY IV BAGS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
• TABLE 353. BRICS EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2018-2024 (USD MILLION)
• TABLE 354. BRICS EMPTY IV BAGS MARKET SIZE, BY NON-PVC, 2025-2032 (USD MILLION)
• TABLE 355. BRICS EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2018-2024 (USD MILLION)
• TABLE 356. BRICS EMPTY IV BAGS MARKET SIZE, BY VOLUME, 2025-2032 (USD MILLION)
• TABLE 357. BRICS EMPTY IV BAGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 358. BRICS EMPTY IV BAGS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 359. BRICS EMPTY IV BAGS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
• TABLE 360. BRICS